Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction

27 August 2022 (17:15 - 18:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Jonathan Cunningham

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

6 More presentations in this session

Presentation thumbnail

Impact of inflammatory phenotype on prognostic discrimination for the novel biomarker cellular communication network factor 1 (CCN1) in patients with dilated cardiomyopathy

Doctor R. Klingenberg (Frankfurt, DE)

Abstract Slides

Presentation thumbnail

NT-proBNP is superior to novel plasma biomarkers for predicting adverse outcome in arrhythmogenic right ventricular cardiomyopathy

Doctor O. Wozniak (Warsaw, PL)

Abstract Slides

Presentation thumbnail

Vascular endothelial factor C and D in patients with heart failure with preserved, mildly reduced, and reduced ejection fraction: the PREHOSP-CHF Study

Doctor M. Iguchi (Kyoto, JP) Professor K. Hasegawa (Kyoto, JP)

Abstract Slides

Presentation thumbnail

Analysis of novel cardiac biomarkers in diagnosis of decompensated heart failure

Doctor R. Pistulli (Munster, DE)

Abstract Slides

Presentation thumbnail

Heart failure is associated with low circulating levels of secreted frizzled receptor protein 5 (Sfrp5).

Mr C. Kelly (Newcastle, AU)

Abstract Slides

Access the full session

Session thumbnail

Biomarkers for heart failure 1

The Event

Event poster

ESC Congress 2022

27 August 2022 17:15 CET

You may be interested in

Congress Session

From genetic signatures to clinical implications

Congress Presentation

A proteo-genomic discovery approach to identify markers of early heart failure

Congress Presentation

State-of-the-art lecture on current state of the diagnosis of heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources